16 commercial payer policies list J9269. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
16 policies from 14 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J9269 |
|---|---|---|
| Elzonris (tagraxofusp-erzs) for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm prn | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Elzonris Prior Authorization Request Form MP 009 prn | Not recorded | Covered with conditionsInferred from policy title |
| Policy | Effective | Status of J9269 |
|---|---|---|
| Oncology - blastic plasmacytoid dendritic cell neoplasm (BPDCN) drug therapy | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Oncology – blastic plasmacytoid dendritic cell neoplasm (BPDCN) drug therapy – Minnesota Health Care Programs | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9269 |
|---|---|---|
| Tagraxofusp-erzs (e.g., Elzonris) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9269 |
|---|---|---|
| Oncology Medications | Oct 1, 2026 | Covered |
| Policy | Effective | Status of J9269 |
|---|---|---|
| Oncology Medications | Oct 1, 2026 | Covered |
| Policy | Effective | Status of J9269 |
|---|---|---|
| Oncology Medications | Oct 1, 2026 | Covered |
| Policy | Effective | Status of J9269 |
|---|---|---|
| Oncology Medications | Oct 1, 2026 | Covered |
| Policy | Effective | Status of J9269 |
|---|---|---|
| Tagraxofusp Erzs Elzonris | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9269 |
|---|---|---|
| Tagraxofusp-erzs (Elzonris) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9269 |
|---|---|---|
| Cigna MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of J9269 |
|---|---|---|
| Tagraxofusp-erzs (Elzonris) | Jul 1, 2019 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9269 |
|---|---|---|
| Q4 - 2026 JHP MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of J9269 |
|---|---|---|
| Tagraxofusp-erzs (Elzonris) | Sep 11, 2020 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9269 |
|---|---|---|
| Elzonris (tagraxofusp-erzs) Listed in Moda Health's provider indexes for Oregon, Alaska, Idaho, Texas. The document does not establish the member's state or line of business. | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |